Amgen | A Worldwide Pioneer in Biotechnology

$name
$name

Science & Innovation 06.05.2025

Meet the Woman Leading the Obesity and Related Conditions Team at Amgen

Seasoned executive Susan Sweeney leads Amgen's ambitious efforts.

Read Story
Arrow
❮1 / 6❯
$name
$name

Responsibility 09.10.2025

Paying Tribute to One of Amgen's Own on 9/11
Read Story
Arrow
❮2 / 6❯
$name
$name

Leadership 09.08.2025

Remembering Dr. David Baltimore: Nobel Laureate and Former Amgen Board Member
Read Story
Arrow
❮3 / 6❯
$name
$name

Patients 09.05.2025

Amgen Once Again Recognized as Top Pharma Company by U.S. Patients
Read Story
Arrow
❮4 / 6❯
$name
$name

Science & Innovation 09.03.2025

Decoding the Genetics of Obesity

How human genetic insights led Amgen researchers to a unique approach in obesity treatment.
Read Story
Arrow
❮5 / 6❯
$name
$name

Press Release 09.02.2025

Amgen Investing More Than Half a Billion Dollars in New, State-Of-The-Art Center for Science and Innovation at U.S. Global Headquarters
Read Press Release
Arrow
❮6 / 6❯
$link.Title
SCIENCE & INNOVATION 08.28.2025

Meet One Amgen Scientist Who Helped Crack the “Undruggable” KRAS Code
$link.Title
SCIENCE & INNOVATION 08.25.2025

Cracking KRAS
$link.Title
SCIENCE & INNOVATION 08.21.2025

From Blocking to Locking: Rethinking How Amgen Intervenes in Disease
$link.Title
SCIENCE & INNOVATION 08.07.2025

Generative AI Tools Support Amgen’s Mission to Serve Patients
$link.Title
PATIENTS 08.06.2025

Missing Coordinates: America’s Cardiology Deserts
$link.Title
LEADERSHIP 08.05.2025

Highlights from Amgen’s 2025 Second Quarter Earnings Report
$link.Title
SCIENCE & INNOVATION 07.15.2025

Inspired by Nature: How Amgen Designs the Future of Medicine
$link.Title
PATIENTS 06.26.2025

Football Legend Barry Sanders Spotlights LDL-C and Heart Attack Risk in New Film
PRESS RELEASE 06.23.2025

Results from Amgen's Phase 2 Obesity Study of Monthly MariTide Presented at the American Diabetes Association 85th Scientific Sessions
MORE STORIES

Our Latest Press Releases

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

More News


Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial.
Click here for more information.

Our Story

Watch VideoLearn more

Our Science

Amgen is a pioneer in the science of using living cells to make biologic medicines.

Our Products

Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.

Our Responsibility

Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.

Amgen Investors

Amgen is a pioneer in the science of using living cells to make biologic medicines, leading and guiding the biotech industry.

Careers With Amgen

Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.